Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - UTAH MEDICAL PRODUCTS INCutmd_ex32z2.htm
EX-32.1 - EXHIBIT 32.1 - UTAH MEDICAL PRODUCTS INCutmd_ex32z1.htm
EX-31.2 - EXHIBIT 31.2 - UTAH MEDICAL PRODUCTS INCutmd_ex31z2.htm
EX-31.1 - EXHIBIT 31.1 - UTAH MEDICAL PRODUCTS INCutmd_ex31z1.htm
EX-23.2 - EXHIBIT 23.2 - UTAH MEDICAL PRODUCTS INCutmd_ex23z2.htm
EX-23.1 - EXHIBIT 23.1 - UTAH MEDICAL PRODUCTS INCutmd_ex23z1.htm
EX-21 - EXHIBIT 21 - UTAH MEDICAL PRODUCTS INCutmd_ex21.htm
10-K - UTAH MEDICAL PRODUCTS INC - FORM 10-K SEC FILING - UTAH MEDICAL PRODUCTS INCutmd-20201231.htm

          Exhibit 10.5

SUMMARY of OFFICER and DIRECTOR COMPENSATION

 

 

The Employment Agreement in Exhibits 7 & 8 of this report is the only written contractual compensation arrangement the Company has with any of its Directors and Executive Officers.  

 

During 2021, the Company’s Chief Executive and Principal Financial Officer (the Company’s “Named Executive Officers”) are scheduled to receive the following compensation from the Company:  

 

Compensation Arrangement

 

 

2021 Scheduled Amount

Base salary

 

$  156,000 (CEO); $113,000 (PFO)

401(k) matching contributions

 

       6,408 (maximum)

Section 125 plan matching contributions (1)

 

          500 (maximum)

Management bonus

 

will be determined at year-end

Pet health benefits (1)

 

          500 (maximum)

Family medical benefits (1)

 

will depend on future events

Travel expense reimbursement (2)

 

      5,000 (CEO); 500 (PFO)

 

 

 

 

 

During 2021, the Company’s Directors are scheduled to receive the following compensation from the Company:

 

Compensation Arrangement

Ernst Hoyer

Barbara Payne

James Beeson

Paul Richins

Base

$  28,000

$  28,000

$  28,000

$28,000

Executive Committee

4,000

-  

-

-

Audit Committee Chairman

4,000

-  

-

-

Travel Expense Reimbursement (2)

250

450

400

50

 

(1)   CEO and PFO participate on the same basis as other eligible employees.

(2)   Estimated 2021 travel expenses on behalf of UTMD business.  The Company reimburses its employees and directors for authorized business expenses.